AVITA Medical, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RCEL Nasdaq 2836 avitamedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AVITA Medical, Inc.

AVITA Medical (RCEL) Stock Sees Fair Value Lift After PermeaDerm Data And Q2 Beat - Oct 1st, 2026 9:09 am
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference - Sep 2nd, 2026 2:10 pm
All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy - Aug 31st, 2026 10:00 am
AVITA Medical (RCEL) Stock Fair Value Rises After PermeaDerm Data And Analyst Target Increases - Aug 25th, 2026 11:07 am
Avita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy? - Aug 24th, 2026 10:00 am
Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft - Aug 19th, 2026 6:02 am
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes - Aug 18th, 2026 5:45 am
Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18% - Aug 16th, 2026 4:01 pm
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds - Aug 16th, 2026 3:01 pm
AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript - Aug 13th, 2026 4:15 pm
AVITA Medical to Host Investor Webinar Briefing - Aug 9th, 2026 4:00 pm
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference - Aug 7th, 2026 6:45 am
AVITA Medical, Inc. Q2 2026 Earnings Call Summary - Aug 7th, 2026 6:30 am
Avita Medical Shares Surge After Record Second-Quarter Performance - Aug 7th, 2026 4:37 am
Avita Medical Q2 Earnings Call Highlights - Aug 7th, 2026 4:03 am
AVITA Medical Inc (AVHHL) (Q2 2026) Earnings Call Highlights: Revenue Surges 18% to $21. ... - Aug 6th, 2026 11:07 pm
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven - Aug 6th, 2026 2:02 pm
AVITA Medical to Announce Second Quarter 2026 Financial Results - Jul 14th, 2026 2:05 pm
AVITA Medical (RCEL) Stock Sees Fair Value Lift As Analysts Back RECELL Momentum - Jul 14th, 2026 10:14 am